Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Fluorodeoxyglucose F18 | 45 | 2024 | 2015 | 5.060 |
Why?
|
Radiopharmaceuticals | 43 | 2024 | 2662 | 3.110 |
Why?
|
Neuroendocrine Tumors | 7 | 2024 | 647 | 2.430 |
Why?
|
Inflammatory Breast Neoplasms | 9 | 2021 | 144 | 2.110 |
Why?
|
Positron-Emission Tomography | 49 | 2024 | 6472 | 2.020 |
Why?
|
Organometallic Compounds | 5 | 2022 | 656 | 1.930 |
Why?
|
Receptors, Peptide | 3 | 2024 | 276 | 1.580 |
Why?
|
Radium | 6 | 2024 | 72 | 1.420 |
Why?
|
Octreotide | 5 | 2024 | 151 | 1.280 |
Why?
|
Lutetium | 3 | 2023 | 34 | 1.120 |
Why?
|
Dipeptides | 4 | 2023 | 409 | 1.120 |
Why?
|
Nuclear Medicine | 8 | 2024 | 234 | 1.110 |
Why?
|
Heterocyclic Compounds, 1-Ring | 3 | 2023 | 65 | 1.080 |
Why?
|
Receptors, Somatostatin | 3 | 2024 | 133 | 1.070 |
Why?
|
Adipose Tissue, Brown | 4 | 2021 | 757 | 1.040 |
Why?
|
Tomography, X-Ray Computed | 29 | 2023 | 20350 | 1.000 |
Why?
|
Bone Neoplasms | 7 | 2024 | 2513 | 0.980 |
Why?
|
Radioimmunotherapy | 7 | 2013 | 90 | 0.970 |
Why?
|
Prostate-Specific Antigen | 9 | 2024 | 2524 | 0.970 |
Why?
|
Hodgkin Disease | 4 | 2022 | 1378 | 0.960 |
Why?
|
Lymphoma | 7 | 2017 | 1892 | 0.950 |
Why?
|
Alpha Particles | 1 | 2024 | 29 | 0.940 |
Why?
|
Dihydrotestosterone | 2 | 2023 | 195 | 0.940 |
Why?
|
Radioisotopes | 7 | 2024 | 497 | 0.690 |
Why?
|
Cyclobutanes | 1 | 2020 | 58 | 0.680 |
Why?
|
Ribs | 1 | 2021 | 245 | 0.680 |
Why?
|
Carboxylic Acids | 1 | 2020 | 92 | 0.680 |
Why?
|
Mouth Neoplasms | 2 | 2022 | 591 | 0.680 |
Why?
|
Ki-67 Antigen | 1 | 2021 | 631 | 0.650 |
Why?
|
Prostatic Neoplasms | 8 | 2024 | 11262 | 0.640 |
Why?
|
Receptors, Androgen | 2 | 2023 | 1068 | 0.630 |
Why?
|
Breast Neoplasms | 11 | 2024 | 20844 | 0.630 |
Why?
|
Hematologic Neoplasms | 2 | 2021 | 1881 | 0.600 |
Why?
|
Diagnostic Imaging | 5 | 2017 | 3509 | 0.550 |
Why?
|
Lymphoma, Large B-Cell, Diffuse | 3 | 2023 | 1396 | 0.540 |
Why?
|
Carcinoma, Lobular | 1 | 2020 | 490 | 0.520 |
Why?
|
Neoplasm Recurrence, Local | 11 | 2024 | 9207 | 0.510 |
Why?
|
Molecular Imaging | 2 | 2012 | 825 | 0.490 |
Why?
|
Biological Products | 1 | 2024 | 900 | 0.480 |
Why?
|
Patient Care Planning | 1 | 2020 | 902 | 0.480 |
Why?
|
Radiometry | 6 | 2023 | 816 | 0.470 |
Why?
|
Stem Cell Transplantation | 3 | 2023 | 1604 | 0.460 |
Why?
|
Humans | 120 | 2024 | 752810 | 0.440 |
Why?
|
Salvage Therapy | 3 | 2024 | 1268 | 0.430 |
Why?
|
Neoplasms | 13 | 2024 | 21810 | 0.430 |
Why?
|
Carcinoma, Ductal, Breast | 1 | 2020 | 1085 | 0.420 |
Why?
|
Radiotherapy | 3 | 2018 | 1507 | 0.410 |
Why?
|
Blood Glucose | 3 | 2018 | 6332 | 0.400 |
Why?
|
Neoplasm Metastasis | 4 | 2020 | 4863 | 0.390 |
Why?
|
Parathyroid Neoplasms | 2 | 2010 | 241 | 0.390 |
Why?
|
Radionuclide Imaging | 7 | 2023 | 1980 | 0.380 |
Why?
|
Colon | 1 | 2019 | 1783 | 0.370 |
Why?
|
Carcinoma | 5 | 2021 | 2341 | 0.360 |
Why?
|
Head and Neck Neoplasms | 3 | 2022 | 2868 | 0.350 |
Why?
|
Tomography, Emission-Computed, Single-Photon | 3 | 2009 | 1069 | 0.340 |
Why?
|
Antibodies, Monoclonal | 6 | 2017 | 9107 | 0.330 |
Why?
|
Hematopoietic Stem Cell Transplantation | 3 | 2023 | 5592 | 0.320 |
Why?
|
Carcinoma, Squamous Cell | 3 | 2022 | 4006 | 0.320 |
Why?
|
Genital Neoplasms, Female | 1 | 2014 | 525 | 0.310 |
Why?
|
Transplantation, Autologous | 4 | 2023 | 2118 | 0.300 |
Why?
|
Prostate | 4 | 2024 | 1784 | 0.300 |
Why?
|
Endometrial Neoplasms | 1 | 2017 | 1359 | 0.300 |
Why?
|
Neoplasm Staging | 10 | 2023 | 11067 | 0.300 |
Why?
|
Hyperparathyroidism | 1 | 2008 | 337 | 0.290 |
Why?
|
Neck Muscles | 1 | 2007 | 100 | 0.290 |
Why?
|
Retrospective Studies | 29 | 2022 | 79160 | 0.280 |
Why?
|
Immunotherapy | 3 | 2022 | 4601 | 0.280 |
Why?
|
Diagnosis, Differential | 9 | 2020 | 12918 | 0.270 |
Why?
|
Middle Aged | 49 | 2024 | 217250 | 0.270 |
Why?
|
Kidney Neoplasms | 3 | 2019 | 4273 | 0.270 |
Why?
|
Male | 53 | 2024 | 355160 | 0.270 |
Why?
|
Female | 57 | 2024 | 386339 | 0.260 |
Why?
|
Cell Proliferation | 2 | 2021 | 10358 | 0.260 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 11 | 2024 | 11603 | 0.260 |
Why?
|
Intercostal Muscles | 1 | 2004 | 26 | 0.250 |
Why?
|
Aged | 42 | 2024 | 166705 | 0.240 |
Why?
|
Lymphatic Diseases | 1 | 2006 | 318 | 0.240 |
Why?
|
Tissue Distribution | 5 | 2019 | 2286 | 0.230 |
Why?
|
Adult | 39 | 2022 | 217168 | 0.230 |
Why?
|
Granulocyte Colony-Stimulating Factor | 1 | 2006 | 622 | 0.220 |
Why?
|
Treatment Outcome | 19 | 2022 | 64288 | 0.220 |
Why?
|
Prostatectomy | 4 | 2024 | 1917 | 0.210 |
Why?
|
Neck | 1 | 2007 | 724 | 0.210 |
Why?
|
Adenoma | 2 | 2010 | 2141 | 0.200 |
Why?
|
Lymphatic Metastasis | 3 | 2021 | 2925 | 0.200 |
Why?
|
Adrenocortical Carcinoma | 1 | 2022 | 86 | 0.200 |
Why?
|
Head | 1 | 2007 | 911 | 0.200 |
Why?
|
Subtraction Technique | 1 | 2004 | 519 | 0.200 |
Why?
|
Taxoids | 2 | 2022 | 667 | 0.190 |
Why?
|
Radiotherapy, Adjuvant | 4 | 2017 | 1773 | 0.190 |
Why?
|
Aged, 80 and over | 22 | 2024 | 58347 | 0.190 |
Why?
|
Mitotic Index | 1 | 2021 | 161 | 0.190 |
Why?
|
Adrenal Cortex Neoplasms | 1 | 2022 | 159 | 0.190 |
Why?
|
Lymphoma, B-Cell | 1 | 2007 | 929 | 0.190 |
Why?
|
Paraganglioma | 1 | 2022 | 140 | 0.180 |
Why?
|
Prognosis | 7 | 2022 | 29369 | 0.180 |
Why?
|
Gastric Emptying | 1 | 2022 | 238 | 0.180 |
Why?
|
Mastectomy | 4 | 2021 | 1822 | 0.180 |
Why?
|
Pheochromocytoma | 1 | 2022 | 326 | 0.180 |
Why?
|
Receptors, Progesterone | 3 | 2020 | 1114 | 0.170 |
Why?
|
Clinical Trials, Phase II as Topic | 1 | 2022 | 626 | 0.170 |
Why?
|
Education, Medical | 1 | 2012 | 1712 | 0.170 |
Why?
|
Fluorine Radioisotopes | 2 | 2021 | 449 | 0.170 |
Why?
|
Radiotherapy Planning, Computer-Assisted | 3 | 2018 | 1676 | 0.170 |
Why?
|
Internship and Residency | 3 | 2022 | 5810 | 0.170 |
Why?
|
Biological Transport | 2 | 2021 | 2073 | 0.160 |
Why?
|
Cholecystokinin | 1 | 2019 | 117 | 0.160 |
Why?
|
Technetium Tc 99m Medronate | 1 | 2019 | 133 | 0.160 |
Why?
|
Chemotherapy, Adjuvant | 4 | 2018 | 3489 | 0.160 |
Why?
|
Survival Analysis | 4 | 2021 | 10187 | 0.160 |
Why?
|
Thyroid Neoplasms | 2 | 2009 | 2309 | 0.160 |
Why?
|
Body Weight | 1 | 2009 | 4605 | 0.160 |
Why?
|
Neoplasm, Residual | 5 | 2023 | 994 | 0.150 |
Why?
|
Radiotherapy Dosage | 5 | 2018 | 2906 | 0.150 |
Why?
|
Gallbladder | 1 | 2019 | 306 | 0.150 |
Why?
|
Gastrointestinal Neoplasms | 2 | 2017 | 950 | 0.150 |
Why?
|
Parathyroid Glands | 2 | 2010 | 519 | 0.140 |
Why?
|
Dose-Response Relationship, Radiation | 2 | 2017 | 873 | 0.140 |
Why?
|
Lymphoma, Mantle-Cell | 1 | 2020 | 239 | 0.140 |
Why?
|
Neoadjuvant Therapy | 5 | 2023 | 2791 | 0.140 |
Why?
|
Practice Guidelines as Topic | 3 | 2024 | 7407 | 0.140 |
Why?
|
Crohn Disease | 1 | 2009 | 2257 | 0.140 |
Why?
|
Adrenal Gland Neoplasms | 1 | 2022 | 732 | 0.140 |
Why?
|
Whole-Body Irradiation | 1 | 2017 | 425 | 0.140 |
Why?
|
Receptor, erbB-2 | 4 | 2020 | 2483 | 0.130 |
Why?
|
Axilla | 1 | 2018 | 612 | 0.130 |
Why?
|
Hepatitis C | 1 | 2006 | 1575 | 0.130 |
Why?
|
Oncology Service, Hospital | 1 | 2016 | 56 | 0.130 |
Why?
|
HSP90 Heat-Shock Proteins | 1 | 2018 | 424 | 0.130 |
Why?
|
Antineoplastic Agents | 6 | 2020 | 13558 | 0.130 |
Why?
|
Uveal Neoplasms | 1 | 2018 | 334 | 0.130 |
Why?
|
Intestinal Neoplasms | 2 | 2018 | 310 | 0.130 |
Why?
|
Lymphoma, Non-Hodgkin | 3 | 2012 | 1377 | 0.120 |
Why?
|
Beta Particles | 1 | 2015 | 47 | 0.120 |
Why?
|
Artifacts | 2 | 2018 | 1891 | 0.120 |
Why?
|
Antibiotics, Antineoplastic | 2 | 2009 | 672 | 0.120 |
Why?
|
Receptors, Estrogen | 2 | 2020 | 2181 | 0.120 |
Why?
|
Sensitivity and Specificity | 7 | 2010 | 14601 | 0.110 |
Why?
|
Remission Induction | 2 | 2017 | 2372 | 0.110 |
Why?
|
Clinical Trials, Phase III as Topic | 1 | 2018 | 851 | 0.110 |
Why?
|
Genes, Retinoblastoma | 1 | 2014 | 125 | 0.110 |
Why?
|
Randomized Controlled Trials as Topic | 2 | 2022 | 10200 | 0.110 |
Why?
|
Pilot Projects | 3 | 2021 | 8449 | 0.110 |
Why?
|
Glucose | 2 | 2022 | 4354 | 0.110 |
Why?
|
Triazoles | 1 | 2018 | 906 | 0.110 |
Why?
|
Combined Modality Therapy | 6 | 2021 | 8549 | 0.110 |
Why?
|
Lymph Node Excision | 1 | 2018 | 1290 | 0.100 |
Why?
|
Cerebral Hemorrhage | 1 | 2023 | 2646 | 0.100 |
Why?
|
Lymphoma, Follicular | 2 | 2013 | 450 | 0.100 |
Why?
|
Vascular Neoplasms | 1 | 2014 | 168 | 0.100 |
Why?
|
Acute Kidney Injury | 1 | 2024 | 1883 | 0.100 |
Why?
|
Medical Oncology | 1 | 2024 | 2284 | 0.100 |
Why?
|
Radiology Department, Hospital | 1 | 2016 | 405 | 0.100 |
Why?
|
Ultrasonography, Mammary | 1 | 2013 | 246 | 0.100 |
Why?
|
Sirolimus | 2 | 2009 | 1535 | 0.100 |
Why?
|
Follow-Up Studies | 4 | 2020 | 39089 | 0.100 |
Why?
|
Societies, Medical | 3 | 2024 | 3834 | 0.090 |
Why?
|
Radiation Dosage | 2 | 2017 | 1968 | 0.090 |
Why?
|
Vena Cava, Inferior | 1 | 2014 | 457 | 0.090 |
Why?
|
Bone Marrow | 3 | 2010 | 2907 | 0.090 |
Why?
|
Imaging, Three-Dimensional | 1 | 2023 | 4035 | 0.090 |
Why?
|
Neoplasms, Multiple Primary | 1 | 2014 | 587 | 0.090 |
Why?
|
Leiomyosarcoma | 1 | 2014 | 426 | 0.090 |
Why?
|
Epithelial Cells | 1 | 2022 | 3672 | 0.090 |
Why?
|
Vaccination | 1 | 2022 | 3321 | 0.080 |
Why?
|
Bone Marrow Neoplasms | 1 | 2010 | 102 | 0.080 |
Why?
|
Mammaplasty | 1 | 2019 | 1216 | 0.080 |
Why?
|
Cold Temperature | 2 | 2010 | 775 | 0.080 |
Why?
|
Oxygen Radioisotopes | 1 | 2008 | 76 | 0.080 |
Why?
|
Fibrous Dysplasia of Bone | 1 | 2008 | 52 | 0.080 |
Why?
|
Rats, Inbred Lew | 2 | 2010 | 1073 | 0.080 |
Why?
|
Ovarian Neoplasms | 2 | 2021 | 4808 | 0.080 |
Why?
|
Carcinoma, Merkel Cell | 1 | 2012 | 319 | 0.080 |
Why?
|
Technetium Tc 99m Sestamibi | 1 | 2008 | 173 | 0.080 |
Why?
|
Intestinal Mucosa | 1 | 2019 | 3003 | 0.080 |
Why?
|
Magnetic Resonance Imaging | 7 | 2023 | 36038 | 0.080 |
Why?
|
Patient Education as Topic | 1 | 2018 | 2292 | 0.080 |
Why?
|
Bronchial Neoplasms | 1 | 2008 | 110 | 0.080 |
Why?
|
Parathyroidectomy | 1 | 2010 | 240 | 0.080 |
Why?
|
Molecular Mimicry | 1 | 2008 | 199 | 0.070 |
Why?
|
Benzamides | 1 | 2013 | 1364 | 0.070 |
Why?
|
Delivery of Health Care, Integrated | 1 | 2016 | 922 | 0.070 |
Why?
|
Hypertrophy | 1 | 2009 | 554 | 0.070 |
Why?
|
Smoking | 1 | 2004 | 9029 | 0.070 |
Why?
|
Hyperparathyroidism, Primary | 1 | 2010 | 162 | 0.070 |
Why?
|
Hematopoiesis, Extramedullary | 1 | 2007 | 53 | 0.070 |
Why?
|
Gastrointestinal Stromal Tumors | 1 | 2013 | 612 | 0.070 |
Why?
|
Survival Rate | 5 | 2017 | 12751 | 0.070 |
Why?
|
Immunologic Factors | 1 | 2016 | 1573 | 0.070 |
Why?
|
Vascular Endothelial Growth Factor A | 1 | 2018 | 3467 | 0.070 |
Why?
|
Population Surveillance | 1 | 2017 | 2598 | 0.070 |
Why?
|
Disease-Free Survival | 5 | 2017 | 6791 | 0.070 |
Why?
|
Hematologic Diseases | 1 | 2010 | 498 | 0.070 |
Why?
|
Longitudinal Studies | 1 | 2023 | 14323 | 0.070 |
Why?
|
Skin Neoplasms | 2 | 2018 | 5722 | 0.070 |
Why?
|
L-Lactate Dehydrogenase | 1 | 2007 | 415 | 0.070 |
Why?
|
Risk | 1 | 2018 | 9613 | 0.070 |
Why?
|
Filgrastim | 1 | 2006 | 129 | 0.070 |
Why?
|
Mastectomy, Modified Radical | 2 | 2017 | 62 | 0.070 |
Why?
|
Radiation Injuries | 1 | 2013 | 1180 | 0.070 |
Why?
|
Constriction, Pathologic | 1 | 2009 | 1099 | 0.070 |
Why?
|
Metabolic Clearance Rate | 1 | 2006 | 363 | 0.070 |
Why?
|
Contrast Media | 1 | 2019 | 5276 | 0.070 |
Why?
|
Hormones | 2 | 2022 | 872 | 0.070 |
Why?
|
Laboratories | 1 | 2009 | 459 | 0.070 |
Why?
|
Pyrimidines | 2 | 2018 | 2979 | 0.060 |
Why?
|
Academic Medical Centers | 1 | 2016 | 2714 | 0.060 |
Why?
|
Thyrotropin | 1 | 2009 | 831 | 0.060 |
Why?
|
Adenocarcinoma, Follicular | 1 | 2009 | 325 | 0.060 |
Why?
|
Drug Evaluation | 1 | 2006 | 642 | 0.060 |
Why?
|
Arteries | 1 | 2010 | 1117 | 0.060 |
Why?
|
Kaplan-Meier Estimate | 4 | 2017 | 6503 | 0.060 |
Why?
|
Muscles | 1 | 2009 | 1579 | 0.060 |
Why?
|
Young Adult | 6 | 2017 | 57732 | 0.060 |
Why?
|
Skull | 1 | 2008 | 811 | 0.060 |
Why?
|
Time Factors | 5 | 2019 | 39885 | 0.060 |
Why?
|
Leukemia | 1 | 2012 | 1502 | 0.060 |
Why?
|
Bleomycin | 2 | 2017 | 496 | 0.060 |
Why?
|
Multivariate Analysis | 2 | 2021 | 12138 | 0.060 |
Why?
|
Thrombocytopenia | 2 | 2010 | 1169 | 0.060 |
Why?
|
Vinblastine | 2 | 2017 | 487 | 0.060 |
Why?
|
Observer Variation | 1 | 2009 | 2581 | 0.060 |
Why?
|
Pelvic Neoplasms | 1 | 2005 | 248 | 0.050 |
Why?
|
Doxorubicin | 3 | 2017 | 2193 | 0.050 |
Why?
|
Piperazines | 1 | 2013 | 2487 | 0.050 |
Why?
|
Carcinoma, Renal Cell | 1 | 2018 | 3176 | 0.050 |
Why?
|
Hernia, Inguinal | 1 | 2005 | 212 | 0.050 |
Why?
|
Mammography | 1 | 2013 | 2434 | 0.050 |
Why?
|
Kinetics | 3 | 2021 | 6352 | 0.050 |
Why?
|
Edetic Acid | 1 | 2023 | 280 | 0.050 |
Why?
|
Aromatase Inhibitors | 1 | 2006 | 510 | 0.050 |
Why?
|
Patient Care Team | 1 | 2013 | 2484 | 0.050 |
Why?
|
Gallium Radioisotopes | 1 | 2023 | 178 | 0.050 |
Why?
|
Drug Administration Schedule | 3 | 2017 | 4883 | 0.050 |
Why?
|
Surgery, Computer-Assisted | 1 | 2010 | 1005 | 0.050 |
Why?
|
Toes | 1 | 2023 | 207 | 0.050 |
Why?
|
Dacarbazine | 2 | 2017 | 560 | 0.050 |
Why?
|
Protein Kinases | 1 | 2009 | 1614 | 0.050 |
Why?
|
Thoracic Vertebrae | 1 | 2006 | 594 | 0.050 |
Why?
|
Tamoxifen | 1 | 2006 | 960 | 0.050 |
Why?
|
Succinate Dehydrogenase | 1 | 2022 | 144 | 0.050 |
Why?
|
United States | 4 | 2024 | 71434 | 0.050 |
Why?
|
Organ Specificity | 1 | 2006 | 1954 | 0.050 |
Why?
|
Leukocytes, Mononuclear | 2 | 2023 | 1820 | 0.050 |
Why?
|
Drug Evaluation, Preclinical | 1 | 2006 | 1347 | 0.050 |
Why?
|
Phantoms, Imaging | 1 | 2009 | 2486 | 0.050 |
Why?
|
Polyethylene Glycols | 1 | 2006 | 1179 | 0.050 |
Why?
|
Proto-Oncogene Proteins c-akt | 1 | 2009 | 2440 | 0.040 |
Why?
|
Adenocarcinoma | 2 | 2008 | 6308 | 0.040 |
Why?
|
Recombinant Proteins | 2 | 2009 | 6513 | 0.040 |
Why?
|
Abdomen | 1 | 2006 | 1112 | 0.040 |
Why?
|
Spleen | 1 | 2006 | 2276 | 0.040 |
Why?
|
Melanoma | 1 | 2018 | 5620 | 0.040 |
Why?
|
Technetium Tc 99m Lidofenin | 1 | 2019 | 3 | 0.040 |
Why?
|
Forecasting | 1 | 2009 | 2917 | 0.040 |
Why?
|
Risk Factors | 3 | 2018 | 73418 | 0.040 |
Why?
|
Spinal Neoplasms | 1 | 2006 | 713 | 0.040 |
Why?
|
Monte Carlo Method | 3 | 2010 | 1268 | 0.040 |
Why?
|
Radiation Tolerance | 1 | 2021 | 476 | 0.040 |
Why?
|
Radioactive Tracers | 1 | 2019 | 67 | 0.040 |
Why?
|
Infusions, Intravenous | 2 | 2017 | 2224 | 0.040 |
Why?
|
Cyclophosphamide | 2 | 2017 | 2202 | 0.040 |
Why?
|
Proportional Hazards Models | 3 | 2021 | 12455 | 0.040 |
Why?
|
Reference Values | 1 | 2006 | 4903 | 0.040 |
Why?
|
Antibodies, Monoclonal, Murine-Derived | 2 | 2012 | 694 | 0.040 |
Why?
|
Clinical Trials as Topic | 1 | 2015 | 7997 | 0.040 |
Why?
|
Prospective Studies | 1 | 2023 | 53833 | 0.040 |
Why?
|
Reproducibility of Results | 4 | 2009 | 19907 | 0.040 |
Why?
|
Rectal Neoplasms | 1 | 2007 | 1145 | 0.040 |
Why?
|
Consent Forms | 1 | 2018 | 55 | 0.040 |
Why?
|
Reoperation | 1 | 2008 | 4257 | 0.040 |
Why?
|
Cytarabine | 1 | 2020 | 698 | 0.040 |
Why?
|
Antineoplastic Agents, Hormonal | 1 | 2006 | 1517 | 0.040 |
Why?
|
Treatment Failure | 2 | 2015 | 2635 | 0.040 |
Why?
|
Europe | 1 | 2024 | 3407 | 0.040 |
Why?
|
Disease Progression | 4 | 2016 | 13403 | 0.040 |
Why?
|
Oligopeptides | 1 | 2023 | 1184 | 0.040 |
Why?
|
Maximum Tolerated Dose | 2 | 2010 | 874 | 0.040 |
Why?
|
Brain Neoplasms | 2 | 2015 | 8895 | 0.030 |
Why?
|
Image Processing, Computer-Assisted | 3 | 2023 | 8954 | 0.030 |
Why?
|
Indazoles | 1 | 2018 | 292 | 0.030 |
Why?
|
Recurrence | 1 | 2008 | 8424 | 0.030 |
Why?
|
Tissue Extracts | 1 | 2016 | 141 | 0.030 |
Why?
|
Career Choice | 1 | 2022 | 751 | 0.030 |
Why?
|
Colonic Neoplasms | 1 | 2007 | 2503 | 0.030 |
Why?
|
Patient Selection | 2 | 2023 | 4239 | 0.030 |
Why?
|
Eating | 1 | 2022 | 1537 | 0.030 |
Why?
|
Acute Disease | 1 | 2006 | 7217 | 0.030 |
Why?
|
Anthracyclines | 1 | 2017 | 282 | 0.030 |
Why?
|
Image Interpretation, Computer-Assisted | 1 | 2008 | 3330 | 0.030 |
Why?
|
Comprehensive Health Care | 1 | 2016 | 124 | 0.030 |
Why?
|
Liver Neoplasms | 1 | 2010 | 4271 | 0.030 |
Why?
|
Bone Remodeling | 1 | 2018 | 579 | 0.030 |
Why?
|
Cohort Studies | 1 | 2017 | 40996 | 0.030 |
Why?
|
Rats | 2 | 2010 | 23565 | 0.030 |
Why?
|
Nausea | 1 | 2017 | 672 | 0.030 |
Why?
|
Immunosuppressive Agents | 1 | 2006 | 4071 | 0.030 |
Why?
|
Delayed-Action Preparations | 1 | 2017 | 963 | 0.030 |
Why?
|
Radiology | 1 | 2007 | 2090 | 0.030 |
Why?
|
Models, Organizational | 1 | 2016 | 548 | 0.030 |
Why?
|
Lymph Nodes | 1 | 2023 | 3474 | 0.030 |
Why?
|
Animals | 4 | 2015 | 166825 | 0.020 |
Why?
|
Dose-Response Relationship, Drug | 2 | 2018 | 10798 | 0.020 |
Why?
|
Body Mass Index | 1 | 2009 | 12794 | 0.020 |
Why?
|
Models, Biological | 1 | 2008 | 9448 | 0.020 |
Why?
|
Radiography | 1 | 2022 | 6964 | 0.020 |
Why?
|
Estrogen Receptor alpha | 1 | 2015 | 577 | 0.020 |
Why?
|
Colorectal Neoplasms | 1 | 2010 | 6793 | 0.020 |
Why?
|
Diabetes Mellitus | 1 | 2009 | 5840 | 0.020 |
Why?
|
B-Lymphocyte Subsets | 1 | 2012 | 242 | 0.020 |
Why?
|
CD8-Positive T-Lymphocytes | 1 | 2024 | 4502 | 0.020 |
Why?
|
Lymphoma, Large-Cell, Anaplastic | 1 | 2012 | 167 | 0.020 |
Why?
|
Urinary Tract | 1 | 2013 | 309 | 0.020 |
Why?
|
Yttrium Radioisotopes | 1 | 2010 | 107 | 0.020 |
Why?
|
Vincristine | 1 | 2012 | 1029 | 0.020 |
Why?
|
Inflammation | 1 | 2009 | 10692 | 0.020 |
Why?
|
Necrosis | 1 | 2013 | 1599 | 0.020 |
Why?
|
Biopsy | 1 | 2021 | 6746 | 0.020 |
Why?
|
Pharyngeal Neoplasms | 1 | 2009 | 113 | 0.020 |
Why?
|
Tonsillar Neoplasms | 1 | 2009 | 50 | 0.020 |
Why?
|
Predictive Value of Tests | 3 | 2010 | 15146 | 0.020 |
Why?
|
Organoplatinum Compounds | 1 | 2010 | 405 | 0.020 |
Why?
|
Absorption | 1 | 2009 | 242 | 0.020 |
Why?
|
Leucovorin | 1 | 2010 | 615 | 0.020 |
Why?
|
Glucose Transporter Type 1 | 1 | 2009 | 187 | 0.020 |
Why?
|
Sulfonamides | 1 | 2018 | 1963 | 0.020 |
Why?
|
Clone Cells | 1 | 2012 | 1654 | 0.020 |
Why?
|
Stomach Neoplasms | 1 | 2018 | 1401 | 0.020 |
Why?
|
Adolescent | 4 | 2012 | 86822 | 0.020 |
Why?
|
Platelet Count | 1 | 2010 | 774 | 0.020 |
Why?
|
Tongue Neoplasms | 1 | 2009 | 183 | 0.020 |
Why?
|
Gastrointestinal Tract | 1 | 2013 | 826 | 0.020 |
Why?
|
Prednisone | 1 | 2012 | 1563 | 0.020 |
Why?
|
Research Design | 1 | 2023 | 6118 | 0.020 |
Why?
|
Leukocyte Count | 1 | 2010 | 1590 | 0.020 |
Why?
|
Neutropenia | 1 | 2012 | 884 | 0.020 |
Why?
|
Herpesvirus 4, Human | 1 | 2012 | 1064 | 0.020 |
Why?
|
Pedigree | 1 | 2014 | 4573 | 0.020 |
Why?
|
Fluorouracil | 1 | 2010 | 1608 | 0.020 |
Why?
|
Pulmonary Alveoli | 1 | 2008 | 649 | 0.020 |
Why?
|
Epstein-Barr Virus Infections | 1 | 2012 | 597 | 0.020 |
Why?
|
Methotrexate | 1 | 2012 | 1703 | 0.020 |
Why?
|
Spinal Cord | 1 | 2013 | 1804 | 0.020 |
Why?
|
Models, Statistical | 2 | 2010 | 5053 | 0.020 |
Why?
|
Fatigue | 1 | 2012 | 1523 | 0.020 |
Why?
|
Blood Flow Velocity | 1 | 2008 | 1369 | 0.020 |
Why?
|
Thorax | 1 | 2007 | 548 | 0.010 |
Why?
|
Quinazolines | 1 | 2010 | 1351 | 0.010 |
Why?
|
Internationality | 1 | 2009 | 987 | 0.010 |
Why?
|
Gastrointestinal Diseases | 1 | 2012 | 1176 | 0.010 |
Why?
|
Thyroidectomy | 1 | 2009 | 896 | 0.010 |
Why?
|
World Health Organization | 1 | 2009 | 1293 | 0.010 |
Why?
|
Bone and Bones | 1 | 2013 | 2550 | 0.010 |
Why?
|
Boston | 1 | 2016 | 9235 | 0.010 |
Why?
|
Mice, Nude | 1 | 2009 | 3582 | 0.010 |
Why?
|
Water | 1 | 2008 | 1395 | 0.010 |
Why?
|
Lung Diseases | 1 | 2012 | 1899 | 0.010 |
Why?
|
Lipid Metabolism | 1 | 2010 | 1894 | 0.010 |
Why?
|
Temporal Lobe | 1 | 2008 | 1690 | 0.010 |
Why?
|
Xenograft Model Antitumor Assays | 1 | 2009 | 3552 | 0.010 |
Why?
|
Pancreatic Neoplasms | 1 | 2018 | 5288 | 0.010 |
Why?
|
Linear Models | 1 | 2010 | 5858 | 0.010 |
Why?
|
Immunohistochemistry | 1 | 2014 | 11004 | 0.010 |
Why?
|
Biomedical Research | 1 | 2016 | 3382 | 0.010 |
Why?
|
Lung Neoplasms | 1 | 2004 | 13173 | 0.010 |
Why?
|
TOR Serine-Threonine Kinases | 1 | 2009 | 2064 | 0.010 |
Why?
|
Clinical Protocols | 1 | 2005 | 1436 | 0.010 |
Why?
|
Child | 1 | 2007 | 78996 | 0.010 |
Why?
|
Preoperative Care | 1 | 2007 | 2234 | 0.010 |
Why?
|
Neutrophils | 1 | 2010 | 3726 | 0.010 |
Why?
|
Phosphorylation | 1 | 2009 | 8314 | 0.010 |
Why?
|
Multiple Myeloma | 1 | 2016 | 5118 | 0.010 |
Why?
|
Mutation | 1 | 2022 | 29712 | 0.010 |
Why?
|
Data Collection | 1 | 2007 | 3302 | 0.010 |
Why?
|
Drug Resistance, Neoplasm | 1 | 2010 | 5164 | 0.010 |
Why?
|
Software | 1 | 2010 | 4422 | 0.010 |
Why?
|
Lung | 1 | 2013 | 9899 | 0.010 |
Why?
|
Quality of Life | 1 | 2016 | 13162 | 0.010 |
Why?
|
Computer Simulation | 1 | 2008 | 6176 | 0.010 |
Why?
|
Genetic Variation | 1 | 2009 | 6510 | 0.010 |
Why?
|
Cell Line, Tumor | 1 | 2009 | 16739 | 0.010 |
Why?
|
Algorithms | 1 | 2010 | 13905 | 0.010 |
Why?
|
Brain | 1 | 2013 | 26820 | 0.000 |
Why?
|
Mice | 1 | 2009 | 80551 | 0.000 |
Why?
|